Delivery Order SPE2DB24D1007-SPE2DB25FCCSV
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectable medication. This firm fixed-price, non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the Place of Performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $11,830 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body injector units on July 29, 2025, with an ultimate completion date of August 19, 2025. This firm fixed price delivery order, which was competitively awarded with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a prescription biologic medication used to treat autoimmune conditions, and...
- The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injectors on July 29, 2025, with completion targeted for August 19, 2025. This non-set-aside award represents a supply of a specialized biologic medication used primarily for dermatological and rheumatological conditions. The delivery order was issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $11,830.00 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 mL on-body 2.4 mL pharmaceutical product. The contract is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and was awarded on July 18, 2025. This award represents a non-set-aside, competitively awarded contract and constitutes a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,830.00 for SKYRIZI 360 mg/2.4 mL on-body injectors on July 23, 2025, with completion expected by August 13, 2025. The contract employs firm fixed pricing with no set-aside designation and represents a competitively awarded transaction. Performance will take place at the vendor's Conshohocken facility. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injectors. This firm fixed-price, competitively awarded contract was issued on July 29, 2025, with an ultimate completion date of August 19, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant medication used in the treatment of moderate-to-severe plaque psoriasis...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 ml on-body injector devices. This firm fixed price delivery order, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a competitive award with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $14,794.36 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, featuring an ultimate completion date of July 31, 2025. The contract was executed on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a $11.83K delivery order to AmerisourceBergen Drug Corp for SKYRIZI 180 mg/1.2 mL on-body autoinjector supplies. The contract, issued on July 31, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This award was competitively awarded with no set-aside designation applied. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $28,396.90 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/ml pen/ml, a pharmaceutical product. The contract, awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed price pricing and carries no set-aside designation, indicating competitive procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCSVDelivery Order
The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 mg/2.4 ml on-body injection medication. This non-set-aside contract, awarded on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a purchase of pharmaceutical supplies to support federal medical procurement needs. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The parent IDC enables the company to supply a broad range of pharmaceutical products and medical commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability to fulfill federal medical supply requirements through competitive procurement, with its extensive contract portfolio spanning specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 8/5/25 |